Concepedia
Statistics
Publications
7
Citations
386
H-Index
Active since
1981
Affiliations
BC Cancer Agency(Current)
Occupational Cancer Research Centre
Brian D. Acker is an author at BC Cancer Agency specializing in medicine, oncology, and cancer pharmacology.
Publications per year
1981–1995
The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
David J. Chaplin, Brian D. Acker · International Journal of Radiation Oncology*Biology*Physics · 1987 · 142 citations
Medicine, Cancer Biology, Pharmacology +12
Small Cell Carcinoma of the Cervix Treated with Concurrent Radiotherapy, Cisplatin, and Etoposide
Paul Hoskins, Frances Wong, K. Swenerton et al. · Gynecologic Oncology · 1995 · 65 citations
Medicine, Oncology, Radiation Oncology +12
Potentiation of the tumor cytotoxicity of melphalan by vasodilating drugs
David J. Chaplin, Brian D. Acker, Peggy L. Olive · International Journal of Radiation Oncology*Biology*Physics · 1989 · 47 citations
Medicine, Oncology, Pharmacology +12
The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988
Gemma Newman, David C. Calverley, Brian D. Acker et al. · Radiotherapy and Oncology · 1992 · 41 citations
Medicine, Oncology, Radiation Oncology +8
Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration
Martin J. Trotter, Brian D. Acker, David J. Chaplin · International Journal of Radiation Oncology*Biology*Physics · 1989 · 38 citations
Medicine, Oncology, Pharmacology +10
1–5 of 7